Literature DB >> 20962547

The retrograde ventriculovenous shunts: the El-Shafei retrograde ventriculojugular and ventriculosinus shunts.

Ismail L El-Shafei1, Hassan I El-Shafei.   

Abstract

Retrograde ventriculovenous (RVV) shunts utilize the impact pressure of the venous bloodstream to maintain the intraventricular pressure more than the pressure in the draining venous channel and to maintain a continuous flow of cerebrospinal fluid (CSF) to the venous circulation at a rate equal to and dependent upon the rate of its formation regardless of changes in posture or intrathoracic pressure, create impact zones which discourage stagnation and clotting of blood at the venous end of the connection and utilize collapse of the internal jugular vein in the erect posture to prevent siphonage. During the past 40 years, 229 RVV shunts were implanted; 219 of the patients (95.63%) benefited from the shunt, and only 2 of them needed a single shunt revision. The manifestations of increased intracranial pressure disappeared, different degrees of regression of the ventriculomegaly occurred in patients with closed craniums but not in infants and young children with open craniums, and there were no problems related to improper CSF drainage or venous thrombosis. The follow-up period is up to 40 years (mean 9 years 8 months).
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20962547     DOI: 10.1159/000316639

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  3 in total

1.  Transcranial Doppler in the evaluation of infants treated with retrograde ventriculosinus shunt.

Authors:  Matheus Fernandes de Oliveira; Manoel Jacobsen Teixeira; Marcelo de Lima Oliveira; Edson Bor Seng-Shu; Karen Andrade Norremose; Fernando Campos Gomes Pinto
Journal:  Childs Nerv Syst       Date:  2016-09-14       Impact factor: 1.475

Review 2.  Cerebrospinal Fluid Shunting Complications in Children.

Authors:  Brian W Hanak; Robert H Bonow; Carolyn A Harris; Samuel R Browd
Journal:  Pediatr Neurosurg       Date:  2017-03-02       Impact factor: 1.162

3.  First-in-human endovascular treatment of hydrocephalus with a miniature biomimetic transdural shunt.

Authors:  Pedro Lylyk; Ivan Lylyk; Carlos Bleise; Esteban Scrivano; Pedro Nicolas Lylyk; Brandon Beneduce; Carl B Heilman; Adel M Malek
Journal:  J Neurointerv Surg       Date:  2021-12-03       Impact factor: 8.572

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.